Engineered Cancer Nanovaccines: A New Frontier in Cancer Therapy

Yijie Wang; Congrui Liu; Chao Fang; Qiuxia Peng; Wen Qin; Xuebing Yan; Kun Zhang

doi:10.1007/s40820-024-01533-y

Nano-Micro Letters (Sep 2024)

Engineered Cancer Nanovaccines: A New Frontier in Cancer Therapy

Yijie Wang,
Congrui Liu,
Chao Fang,
Qiuxia Peng,
Wen Qin,
Xuebing Yan,
Kun Zhang

Affiliations

Yijie Wang: Central Laboratory and Department of Medical Ultrasound, Sichuan Academy of Medical Sciences, Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China
Congrui Liu: Central Laboratory and Department of Medical Ultrasound, Sichuan Academy of Medical Sciences, Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China
Chao Fang: Central Laboratory and Department of Medical Ultrasound, Sichuan Academy of Medical Sciences, Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China
Qiuxia Peng: Central Laboratory and Department of Medical Ultrasound, Sichuan Academy of Medical Sciences, Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China
Wen Qin: Central Laboratory and Department of Medical Ultrasound, Sichuan Academy of Medical Sciences, Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China
Xuebing Yan: Jiangsu Provincial Innovation and Practice Base for Postdoctors, Suining People’s Hospital, Affiliated Hospital of Xuzhou Medical University
Kun Zhang: Central Laboratory and Department of Medical Ultrasound, Sichuan Academy of Medical Sciences, Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China

DOI: https://doi.org/10.1007/s40820-024-01533-y
Journal volume & issue: Vol. 17, no. 1
pp. 1 – 35

Abstract

Read online

Highlights We classified the carriers that built cancer nanovaccines, discussed their diversified applications and coincidently compared their advantages and disadvantages. Various cellular targets that guide the design and engineering of cancer nanovaccines are categorized and their characteristics and benefits are highlighted. The clinical cases and encountered challenges in cancer nanovaccines are discussed, during which reasonable solutions and future research direction are provided.

Published in Nano-Micro Letters

ISSN: 2311-6706 (Print); 2150-5551 (Online)
Publisher: SpringerOpen
Country of publisher: Germany
LCC subjects: Technology
Website: http://www.springer.com/40820

About the journal

Abstract

Keywords